![Prebiopsy mpMRI of a 65-year-old patient (PSA level 5.82 ng/mL). (a)... | Download Scientific Diagram Prebiopsy mpMRI of a 65-year-old patient (PSA level 5.82 ng/mL). (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/319485368/figure/fig1/AS:540342232588289@1505839035992/Prebiopsy-mpMRI-of-a-65-year-old-patient-PSA-level-582-ng-mL-a-Transverse-T.png)
Prebiopsy mpMRI of a 65-year-old patient (PSA level 5.82 ng/mL). (a)... | Download Scientific Diagram
![Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer | BMC Urology Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer | BMC Urology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-020-00659-6/MediaObjects/12894_2020_659_Fig4_HTML.png)
Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer | BMC Urology
![Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer - Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -](https://onlinelibrary.wiley.com/cms/asset/996705c8-2b61-4e84-a43c-a508f95db426/ntbl003.jpg)
Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -
![Integrated formulas to forecast prostate cancer: the parameters of influencing the prostate specific antigen level as an adjunct to prostate specific antigen and multi-parametric MRI to predict prostate cancer before biopsy - Integrated formulas to forecast prostate cancer: the parameters of influencing the prostate specific antigen level as an adjunct to prostate specific antigen and multi-parametric MRI to predict prostate cancer before biopsy -](https://cdn.amegroups.cn/journals/pbpc/files/journals/3/articles/17515/public/17515-PB6-R1.png/w300)
Integrated formulas to forecast prostate cancer: the parameters of influencing the prostate specific antigen level as an adjunct to prostate specific antigen and multi-parametric MRI to predict prostate cancer before biopsy -
![Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging | Journal of Nuclear Medicine Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/62/7/961/F1.large.jpg)
Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging | Journal of Nuclear Medicine
![PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/251be2484ab726805c25860ba5917364701380f4/2-Table1-1.png)
PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar
![Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.351.issue-2/nejmoa032975/production/images/img_medium/nejmoa032975_t2.jpeg)
Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM
![Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l | Journal of Urology Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l | Journal of Urology](https://www.auajournals.org/cms/asset/a69b46f8-cfb3-4da1-9770-63a65b5b9764/si1.gif)
Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l | Journal of Urology
![JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions](https://www.mdpi.com/jcm/jcm-09-03400/article_deploy/html/images/jcm-09-03400-g001.png)
JCM | Free Full-Text | The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
![Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature - European Urology Oncology Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature - European Urology Oncology](https://euoncology.europeanurology.com/cms/asset/01d4a800-0d15-4ea7-b280-fd90ecb935db/gr1.jpg)